Inpatient Neurologic Consultation in Solid Organ Transplant Patients

Abstract

A third of solid organ transplant recipients experience neurologic complications after transplantation. In this article the author reviews common and uncommon complications of the perioperative period including stroke and peripheral neuropathy, neurotoxicity associated with immunosuppressant medications such as calcineurin inhibitors, and opportunistic infections that target the nervous system. A careful clinical history, neurologic examination, and medication review are vital in generating a differential diagnosis that will guide diagnostic testing and decisions regarding treatment and management, and early recognition of many disorders is imperative to prevent irreversible neurologic morbidity and death.

Keywords

transplant medicine - encephalopathy - posterior reversible encephalopathy syndrome - calcineurin inhibitor toxicity - opportunistic infections

• References

• 1 Organ Procurement and Transplantation Network. Available at: http://optn.transplant.hrsa.gov /converge/latestData/rptData.asp . Accessed June 15, 2015
• 2 Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int 2009; 22 (3) 269-278
• 3 Jarquin-Valdivia AA, Wijdicks EFM, McGregor C. Neurologic complications following heart transplantation in the modern era: decreased incidence, but postoperative stroke remains prevalent. Transplant Proc 1999; 31 (5) 2161-2162
• 4 Belvís R, Martí-Fàbregas J, Cocho D , et al. Cerebrovascular disease as a complication of cardiac transplantation. Cerebrovasc Dis 2005; 19 (4) 267-271
• 5 Zierer A, Melby SJ, Voeller RK , et al. Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg 2007; 83 (5) 1684-1690
• 6 van de Beek D, Kremers W, Daly RC , et al. Effect of neurologic complications on outcome after heart transplant. Arch Neurol 2008; 65 (2) 226-231
• 7 Muñoz P, Valerio M, Palomo J , et al. Infectious and non-infectious neurologic complications in heart transplant recipients. Medicine (Baltimore) 2010; 89 (3) 166-175
• 8 Lund LH, Edwards LB, Kucheryavaya AY , et al; International Society of Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant 2014; 33 (10) 996-1008
• 9 Mateen FJ, Dierkhising RA, Rabinstein AA, van de Beek D, Wijdicks EFM. Neurological complications following adult lung transplantation. Am J Transplant 2010; 10 (4) 908-914
• 10 Shigemura N, Sclabassi RJ, Bhama JK , et al. Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome. Transplantation 2013; 95 (6) 866-871
• 11 Aull-Watschinger S, Konstantin H, Demetriou D , et al. Pre-transplant predictors of cerebrovascular events after kidney transplantation. Nephrol Dial Transplant 2008; 23 (4) 1429-1435
• 12 Colombari RC, de Ataíde EC, Udo EY, Falcão ALE, Martins LC, Boin IFSF. Neurological complications prevalence and long-term survival after liver transplantation. Transplant Proc 2013; 45 (3) 1126-1129
• 13 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24) 1581-1587
• 14 Chalela JA, Katzan I, Liebeskind DS , et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke 2001; 32 (6) 1365-1369
• 15 Ahmari SAL, Bunch TJ, Chandra A , et al. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant 2006; 25 (1) 53-60
• 16 Gialdini G, Nearing K, Bhave PD , et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312 (6) 616-622
• 17 Saner FH, Sotiropoulos GC, Gu Y , et al. Severe neurological events following liver transplantation. Arch Med Res 2007; 38 (1) 75-79
• 18 Zivković SA. Neurologic complications after liver transplantation. World J Hepatol 2013; 5 (8) 409-416
• 19 Bernhardt M, Pflugrad H, Goldbecker A , et al. Central nervous system complications after liver transplantation: common but mostly transient phenomena. Liver Transpl 2015; 21 (2) 224-232
• 20 Wijdicks EFM, Hocker SE. Neurologic complications of liver transplantation. Handb Clin Neurol 2014; 121: 1257-1266
• 21 Navarro V, Varnous S, Galanaud D , et al. Incidence and risk factors for seizures after heart transplantation. J Neurol 2010; 257 (4) 563-568
• 22 Hinchey J, Chaves C, Appignani B , et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (8) 494-500
• 23 Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010; 112 (10) 886-891
• 24 Arimura FE, Camargo PCLB, Costa AN , et al. Posterior reversible encephalopathy syndrome in lung transplantation: 5 case reports. Transplant Proc 2014; 46 (6) 1845-1848
• 25 Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008; 29 (5) 924-930
• 26 Qin W, Tan CY, Huang X, Huang Z, Tao Y, Fu P. Rapamycin-induced posterior reversible encephalopathy in a kidney transplantation patient. Int Urol Nephrol 2011; 43 (3) 913-916
• 27 van de Beek D, Kremers WK, Kushwaha SS, McGregor CG, Wijdicks EF. No major neurologic complications with sirolimus use in heart transplant recipients. Mayo Clin Proc 2009; 84 (4) 330-332
• 28 Yamaguchi I, Ichikawa T, Nakao K , et al. Cerebellar ataxia in a patient receiving calcineurin inhibitors after living donor liver transplantation: a case report. Transplant Proc 2007; 39 (10) 3495-3497
• 29 Kaczmarek I, Schmauss D, Sodian R , et al. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient. J Heart Lung Transplant 2007; 26 (1) 89-92
• 30 Sierra-Hidalgo F, Martínez-Salio A, Moreno-García S, de Pablo-Fernández E, Correas-Callero E, Ruiz-Morales J. Akinetic mutism induced by tacrolimus. Clin Neuropharmacol 2009; 32 (5) 293-294
• 31 Venneti S, Moss HE, Levin MH , et al. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci 2011; 301 (1–2) 112-115
• 32 Fukazawa K, Nishida S, Aguina L, Pretto Jr E. Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. Ann Transplant 2011; 16 (3) 139-142
• 33 DiMartini A, Fontes P, Dew MA, Lotrich FE, de Vera M. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008; 14 (6) 815-822
• 34 Hayes Jr D, Adler B, Turner TL, Mansour HM. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. Pediatr Neurol 2014; 50 (3) 272-275
• 35 Echaniz-Laguna A, de Séze J, Chanson J-B. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study. J Neurol Neurosurg Psychiatry 2012; 83 (7) 699-705
• 36 Bhagavati S, Maccabee P, Muntean E, Sumrani NB. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports. Transplant Proc 2007; 39 (10) 3465-3467
• 37 Labate A, Morelli M, Palamara G, Pirritano D, Quattrone A. Tacrolimus-induced polyneuropathy after heart transplantation. Clin Neuropharmacol 2010; 33 (3) 161-162
• 38 Pfitzmann R, Klupp J, Langrehr JM , et al. Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003; 76 (1) 130-136
• 39 Martin MA, Massanari RM, Nghiem DD, Smith JL, Corry RJ. Nosocomial aseptic meningitis associated with administration of OKT3. JAMA 1988; 259 (13) 2002-2005
• 40 Zonios DI, Gea-Banacloche J, Childs R, Bennett JE. Hallucinations during voriconazole therapy. Clin Infect Dis 2008; 47 (1) e7-e10
• 41 Muller MP, Richardson DC, Walmsley SL. Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. Clin Nephrol 2001; 55 (1) 80-84
• 42 Koller WC, Gehlmann LK, Malkinson FD, Davis FA. Dapsone-induced peripheral neuropathy. Arch Neurol 1977; 34 (10) 644-646
• 43 Hall WA, Martinez AJ, Dummer JS , et al. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol 1989; 46 (2) 173-177
• 44 van de Beek D, Patel R, Daly RC, McGregor CGA, Wijdicks EFM. Central nervous system infections in heart transplant recipients. Arch Neurol 2007; 64 (12) 1715-1720
• 45 Peleg AY, Husain S, Qureshi ZA , et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007; 44 (10) 1307-1314
• 46 Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery 1994; 35 (4) 622-631
• 47 Mizuno S, Zendejas IR, Reed AI , et al. Listeria monocytogenes following orthotopic liver transplantation: central nervous system involvement and review of the literature. World J Gastroenterol 2007; 13 (32) 4391-4393
• 48 Boon AP, Adams DH, Buckels J, McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol 1990; 43 (2) 114-118
• 49 Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002; 4 (4) 183-188
• 50 Singh N, Alexander BD, Lortholary O , et al; Cryptococcal Collaborative Transplant Study Group. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007; 195 (5) 756-764
• 51 Fernàndez-Sabé N, Cervera C, Fariñas MC , et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis 2012; 54 (3) 355-361
• 52 Bodro M, Sabé N, Santín M , et al. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Transplant Proc 2012; 44 (9) 2686-2689
• 53 Nelson CA, Zunt JR. Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis 2011; 53 (9) 915-926
• 54 El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren CT. Guillain-Barré syndrome after solid organ transplantation. Transplantation 2001; 71 (9) 1311-1316
• 55 Seeley WW, Marty FM, Holmes TM , et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69 (2) 156-165
• 56 Verhelst X, Vanhooren G, Vanopdenbosch L , et al. Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transpl Int 2011; 24 (4) e30-e34
• 57 Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf . Accessed July 15, 2015
• 58 Winston DJ, Vikram HR, Rabe IB , et al; West Nile Virus Transplant-Associated Transmission Investigation Team. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation 2014; 97 (9) 881-889
• 59 Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995; 59 (2) 240-244
• 60 Cavaliere R, Petroni G, Lopes MB, Schiff D ; International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system post-transplantation lymphoproliferative disorder: an international primary central nervous system lymphoma collaborative group report. Cancer 2010; 116 (4) 863-870
• 61 Lake W, Chang JE, Kennedy T, Morgan A, Salamat S, Başkaya MK. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics. Neurosurgery 2013; 72 (6) 960-970 , discussion 970